Bob T. Li, MD, MPH
Articles
Expert Discusses KRAS G12C Inhibitors for Patients with NSCLC
November 18, 2019
Video
Future treatment for patients with the KRAS G12C mutation in NSCLC shows potential promise, according to a principal investigator studying the AMG 510 inhibitor.